Overview

Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice

Status:
COMPLETED

Trial end date:
2025-03-19

Target enrollment:

Participant gender:

Summary

Investigating the efficacy, safety, and molecular mechanism of Pentoxifylline supplementation in improving elevated direct bilirubin level and liver function tests in patients with hepatic and post-hepatic jaundice

Phase:

PHASE2

Details

Lead Sponsor:

Tanta University

Treatments:

Pentoxifylline